文献速递鼻科小儿耳鼻咽喉

儿童鼻源性颅内化脓:系统综述与荟萃分析

Sinogenic Intracranial Suppuration in Children: Systematic Review and Meta-analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-09-07

该系统综述与荟萃分析纳入32项回顾性观察研究共533例儿童鼻源性颅内化脓患者,跨越1975至2020年。汇总90天死亡率为2.3%,永久性神经功能障碍为21.3%,重返手术率为37.3%,45年间无显著变化。内镜鼻窦手术使用率58.4%且近年呈上升趋势,但未与死亡率、翻修手术需求或神经功能障碍改善相关。

要点

  • 儿童鼻源性颅内化脓90天死亡率2.3%,永久性神经功能障碍21.3%,重返手术率37.3%。
  • 过去45年上述结局无显著改善。
  • 内镜鼻窦手术使用率上升,但未改善死亡率、翻修手术需求或神经功能障碍。

核心结论

  • 儿童鼻源性颅内化脓的结局在过去45年未改变,内镜鼻窦手术未与患者结局改善相关。
  • 需进一步高质量研究确定最佳治疗方式以降低儿童鼻源性颅内化脓的疾病负担。

研究设计与样本

  • 系统检索Medline、Embase、Cochrane和ClinicalTrials.gov数据库。
  • 纳入32项回顾性观察研究,共533例年龄<18岁的鼻源性硬膜下积脓、硬膜外脓肿和脑实质脓肿患者,研究跨越1975至2020年。
  • 采用随机效应荟萃分析和荟萃回归评估时间及内镜鼻窦手术对结局的影响。

主要发现

  • 90天死亡率汇总估计为2.3%(95% CI,1.1%-3.6%;I2=0,P>.99)。
  • 永久性神经功能障碍汇总估计为21.3%(95% CI,15.3%-27.3%;I2=75.2%,P<.001)。
  • 重返手术率汇总估计为37.3%(95% CI,29.5%-45%;I2=71.2%,P<.001)。
  • 上述结局在研究期间无显著差异。
  • 内镜鼻窦手术汇总估计为58.4%(95% CI,44.2%-72.6%;I2=97.1%,P<.001),近年使用呈显著增加趋势,但未与死亡率、翻修手术需求或神经功能障碍改善相关。

临床怎么用

  • 临床医生应认识到儿童鼻源性颅内化脓的死亡率、神经功能障碍和重返手术风险仍较高。
  • 内镜鼻窦手术使用增加但未显示结局获益,治疗决策需综合考虑。

局限性

  • 纳入研究均为回顾性观察研究,存在固有偏倚。
  • 研究异质性较高(如永久性神经功能障碍I2=75.2%,内镜鼻窦手术I2=97.1%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate temporal trends in the management of sinogenic intracranial suppuration and its outcomes in children. DATA SOURCES: A systematic search of databases was performed (Medline, Embase, Cochrane, ClinicalTrials.gov). REVIEW METHODS: Studies in children (age <18 years) with sinogenic subdural empyema, extradural abscess, and intraparenchymal abscess were included. Data on treatment strategies were extracted. Primary outcome was death <90 days. Secondary outcomes were return to theater, neurologic disability at 6 months, and length of stay. Random effects meta-analysis and meta-regression were performed to investigate the effect of time and endoscopic sinus surgery (ESS) on these outcomes. RESULTS: A total of 32 retrospective observational studies involving 533 patients recruited across a 45-year period (1975-2020) were included. The pooled estimates for 90-day mortality, permanent neurologic disability, and return to theater were 2.3% (95% CI, 1.1%-3.6%; I2 = 0, P > .99), 21.3% (95% CI, 15.3%-27.3%; I2 = 75.2%, P < .001), and 37.3% (95% CI, 29.5%-45%; I2 = 71.2%, P < .001), respectively, with no significant differences found across the study period. The pooled estimate for ESS was 58.4% (95% CI, 44.2%-72.6%; I2 = 97.1%, P < .001) with a significantly increasing trend in its use in the more recent years. ESS was not associated with improved mortality, reduced need for revision surgery, or neurologic disability. CONCLUSION: The outcomes of sinogenic intracranial complications have not changed over the last 45 years, and ESS was not associated with improved patient outcomes. Further high-quality studies are required to determine the most appropriate treatment modalities to improve the burden of morbidity associated with sinogenic intracranial suppuration in children.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Milinis K, Thompson N, Atsmoni SC, et al. Sinogenic Intracranial Suppuration in Children: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2021. PMID: 34491863. doi:10.1177/01945998211043847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。